Malin Corporation | MLC - PE Price to Earnings


Malin Corporation reported 11.81 in PE Price to Earnings for its fiscal semester ending in June of 2023.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
ALKERMES 262.4 126.59 Sep/2026
Dianthus Therapeutics 3.8 1.53 Sep/2024
Eurofins Scientific SE 23.63 0.84 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 29.03 7.58 Sep/2026
Lonza 34.34 2.58 Dec/2025
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Organon & Co 17.56 3 Sep/2026
Ovoca Bio 1.83 3.29 Jun/2024
Revvity 56.86 20.39 Sep/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 34.47 19.86 Jun/2026
Xeris Pharmaceuticals 92.28 16.23 Jun/2026